Efficacy of cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITHOC) in thymic neoplasia: a systematic review and single-arm meta-analysis
REN da Nobrega Oliveira… - Annals of Surgical …, 2024 - Springer
Introduction The study was designed to evaluate the efficacy and safety of hyperthermic
intrathoracic chemotherapy (HITHOC) as an adjuvant treatment for thymic epithelial tumors …
intrathoracic chemotherapy (HITHOC) as an adjuvant treatment for thymic epithelial tumors …
Perioperative management and postoperative outcomes of locally advanced thymic epithelial tumors: A narrative review
M Takenaka, K Kuroda, F Tanaka - Mediastinum, 2023 - pmc.ncbi.nlm.nih.gov
Background and Objective Thymic epithelial tumors (TETs) are frequently diagnosed at an
advanced stage, highlighting the importance of understanding the treatment strategies for …
advanced stage, highlighting the importance of understanding the treatment strategies for …
Clinical features and prognostic factors in thymoma and thymic carcinoma
D Bayram, S Sekmek, M Kayaalp, M Bardakçı… - Indian Journal of …, 2024 - Springer
Introduction Thymic epithelial tumors represent the most common cause of anterior
mediastinal masses in adults. Among these tumors, thymomas constitute the majority …
mediastinal masses in adults. Among these tumors, thymomas constitute the majority …
Postoperative irradiation in stage II thymomas: is it worth it?—shedding some light in the guidelines' gray zone
Thymomas are rare, indolent tumors. Early stages (I–II) benefit from surgical treatment, while
locally advanced diseases (stages III–IV) usually require a multidisciplinary approach. The …
locally advanced diseases (stages III–IV) usually require a multidisciplinary approach. The …
[HTML][HTML] 一例Masaok IVa 期巨大胸腺瘤的治疗回顾及文献复习
周镇锋， 龙浩健， 黎山， 赵建夫 - Advances in Clinical Medicine, 2024 - hanspub.org
临床上巨大胸腺瘤案例罕见, 对于IVa 期巨大胸腺瘤治疗方法尚无共识, 且可供选择的治疗方法
又尤为缺乏. 本文介绍一例35 岁Masaoka IVa 期巨大胸腺瘤的患者, 行手术切除后联合化疗及 …
又尤为缺乏. 本文介绍一例35 岁Masaoka IVa 期巨大胸腺瘤的患者, 行手术切除后联合化疗及 …
Updated Outcomes of Surgical Treatment for Recurrent Thymic Tumor: A Report from the Japanese Nationwide Database
T Mizuno, TF Chen-Yoshikawa, I Yoshino… - Interdisciplinary …, 2024 - academic.oup.com
OBJECTIVES This study aimed to analyze the surgical outcomes for recurrent thymic
epithelial tumors and identify the factors associated with post-recurrence survival, using an …
epithelial tumors and identify the factors associated with post-recurrence survival, using an …
Re-evaluation and operative indications after induction therapy for thymic epithelial tumors
Y Yamada, M Hamaji, H Okada, A Takahagi… - …, 2024 - pmc.ncbi.nlm.nih.gov
Thymic epithelial tumors (TETs), encompassing thymoma and thymic carcinoma, represent a
rare and heterogeneous group of thoracic malignancies with varying prognoses and …
rare and heterogeneous group of thoracic malignancies with varying prognoses and …
[PDF][PDF] Postoperative radiotherapy for thymic epithelial tumors: a narrative review
N Kishi, Y Matsuo - Mediastinum, 2024 - cdn.amegroups.cn
Conclusions: This review consolidates the literature on PORT for TETs, factoring in the
Masaoka-Koga staging, WHO histological subtypes, and resection status. Varying results …
Masaoka-Koga staging, WHO histological subtypes, and resection status. Varying results …